The Hydroxamic Acids as Potential Anticancer and Neuroprotective Agents
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Hydroxamic acids are a promising class of chemical compounds with proven antitumor potential, primarily due to their ability to inhibit the activity of histone deacetylase enzymes. The analysis of modern experimental data shows a wide range of biological activities of hydroxamic acids, which make them equally worthy candidates for the fight against neuropathologies. A characteristic feature of hydroxamic acids is their ability to act simultaneously on several promising molecular targets for the correction of both neuropathologies and oncological diseases, thereby exhibiting multifunctionality. This review discusses the effect of hydroxamic acids on key parts of cancer and neurodegenerative disorders' pathogenesis. Pathological changes in the processes associated with oxidative stress, the functioning of mitochondria, and the activity of metal enzymes of the class of histone deacetylases, as the main links in the epigenetic regulation of pathological conditions, are such molecular targets.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Current medicinal chemistry - 28(2021), 39 vom: 20., Seite 8139-8162 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Neganova, Margarita E [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 29.12.2021 Date Revised 29.12.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/0929867328666201218123154 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM319072509 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM319072509 | ||
003 | DE-627 | ||
005 | 20231225170700.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0929867328666201218123154 |2 doi | |
028 | 5 | 2 | |a pubmed24n1063.xml |
035 | |a (DE-627)NLM319072509 | ||
035 | |a (NLM)33342403 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Neganova, Margarita E |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Hydroxamic Acids as Potential Anticancer and Neuroprotective Agents |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.12.2021 | ||
500 | |a Date Revised 29.12.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Hydroxamic acids are a promising class of chemical compounds with proven antitumor potential, primarily due to their ability to inhibit the activity of histone deacetylase enzymes. The analysis of modern experimental data shows a wide range of biological activities of hydroxamic acids, which make them equally worthy candidates for the fight against neuropathologies. A characteristic feature of hydroxamic acids is their ability to act simultaneously on several promising molecular targets for the correction of both neuropathologies and oncological diseases, thereby exhibiting multifunctionality. This review discusses the effect of hydroxamic acids on key parts of cancer and neurodegenerative disorders' pathogenesis. Pathological changes in the processes associated with oxidative stress, the functioning of mitochondria, and the activity of metal enzymes of the class of histone deacetylases, as the main links in the epigenetic regulation of pathological conditions, are such molecular targets | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Hydroxamic acids | |
650 | 4 | |a cancer | |
650 | 4 | |a histone deacetylase. | |
650 | 4 | |a mitochondria | |
650 | 4 | |a neurodegenerative diseases | |
650 | 4 | |a oxidative stress | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Histone Deacetylase Inhibitors |2 NLM | |
650 | 7 | |a Hydroxamic Acids |2 NLM | |
650 | 7 | |a Neuroprotective Agents |2 NLM | |
700 | 1 | |a Klochkov, Sergey G |e verfasserin |4 aut | |
700 | 1 | |a Aleksandrova, Yulia R |e verfasserin |4 aut | |
700 | 1 | |a Aliev, Gjumrakch |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current medicinal chemistry |d 1997 |g 28(2021), 39 vom: 20., Seite 8139-8162 |w (DE-627)NLM093833857 |x 1875-533X |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2021 |g number:39 |g day:20 |g pages:8139-8162 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0929867328666201218123154 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2021 |e 39 |b 20 |h 8139-8162 |